{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:54Z","timestamp":1762005354559,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["171144\/2017\u20131"],"award-info":[{"award-number":["171144\/2017\u20131"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11102-021-01204-w","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:04:41Z","timestamp":1643328281000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A prospective study on the efficacy of oral estrogen in female patients with acromegaly"],"prefix":"10.1007","volume":"25","author":[{"given":"J.","family":"Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. B.","family":"Lamback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Chimelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-3192","authenticated-orcid":false,"given":"L.","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"8","key":"1204_CR1","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jcem.83.8.4995","volume":"83","author":"S Melmed","year":"1998","unstructured":"Melmed S, Jackson I, Kleinberg D, Klibanski A (1998) Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 83(8):2646\u20132652. https:\/\/doi.org\/10.1210\/jcem.83.8.4995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332. https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"issue":"3","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ecl.2020.05.007","volume":"49","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Lamback EB, Gadelha MR (2020) Acromegaly: update on management and long-term morbidities. Endocrinol Metab Clin North Am 49(3):475\u2013486. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC et al (2010) Mortality in patients with pituitary disease. Endocr Rev 31(3):301\u2013342. https:\/\/doi.org\/10.1210\/er.2009-0033","journal-title":"Endocr Rev"},{"issue":"2","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159(2):89\u201395. https:\/\/doi.org\/10.1530\/EJE-08-0267","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/jc.2004-1381","volume":"90","author":"R Kauppinen-Makelin","year":"2005","unstructured":"Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H et al (2005) A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 90(7):4081\u20134086. https:\/\/doi.org\/10.1210\/jc.2004-1381","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","author":"A Giustina","year":"2019","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C et al (2019) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1210\/jc.2008-2421","volume":"94","author":"S Melmed","year":"2009","unstructured":"Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D et al (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509\u20131517. https:\/\/doi.org\/10.1210\/jc.2008-2421","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1204_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/jcem-34-1-51","volume":"34","author":"E Wiedemann","year":"1972","unstructured":"Wiedemann E, Schwartz E (1972) Suppression of growth hormone-dependent human serum sulfation factor by estrogen. J Clin Endocrinol Metab 34(1):51\u201358. https:\/\/doi.org\/10.1210\/jcem-34-1-51","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0002-9343(80)90470-2","volume":"69","author":"DR Clemmons","year":"1980","unstructured":"Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Kjellberg RN, Van Wyk JJ (1980) Estradiol treatment of acromegaly: reduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med 69(4):571\u2013575. https:\/\/doi.org\/10.1016\/0002-9343(80)90470-2","journal-title":"Am J Med"},{"key":"1204_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1530\/acta.0.0370138","volume":"37","author":"S Almqvist","year":"1961","unstructured":"Almqvist S, Ikkos D, Luft R (1961) Studies on sulfation factor (SF) activity of human serum: the effects of oestrogen and X-ray therapy on serum SF activity in acromegaly. Acta Endocrinol 37:138\u2013147. https:\/\/doi.org\/10.1530\/acta.0.0370138","journal-title":"Acta Endocrinol"},{"issue":"3","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB et al (2016) U. S. medical eligibility criteria for contraceptive use 2016. MMWR Recomm Rep 65(3):1\u2013103. https:\/\/doi.org\/10.15585\/mmwr.rr6503a1","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610\u2013617. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"issue":"4","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko AS, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803\u2013811. https:\/\/doi.org\/10.3171\/2014.12.JNS141083","journal-title":"J Neurosurg"},{"key":"1204_CR15","first-page":"989","volume":"87","author":"G Di Chiro","year":"1962","unstructured":"Di Chiro G, Nelson KB (1962) The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med 87:989\u20131008","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"1204_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09531-x","author":"L Kasuki","year":"2019","unstructured":"Kasuki L, Raverot G (2019) Definition and diagnosis of aggressive pituitary tumors. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-019-09531-x","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"issue":"4","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535. https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","volume":"60","author":"X Antunes","year":"2018","unstructured":"Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM et al (2018) Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3):415\u2013422. https:\/\/doi.org\/10.1007\/s12020-018-1590-8","journal-title":"Endocrine"},{"key":"1204_CR20","first-page":"121","volume":"11","author":"OLWR Kirklin","year":"1936","unstructured":"Kirklin OLWR (1936) Follicular hormone administration in acromegaly. Proc Mayo Clin 11:121","journal-title":"Proc Mayo Clin"},{"issue":"5","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693\u2013721. https:\/\/doi.org\/10.1210\/er.2003-0035","journal-title":"Endocr Rev"},{"issue":"3","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH et al (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100(3):1016\u20131021. https:\/\/doi.org\/10.1073\/pnas.0337600100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/endo.139.4.5931","volume":"139","author":"L Fernandez","year":"1998","unstructured":"Fernandez L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldosen LA et al (1998) Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)\/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology 139(4):1815\u20131824. https:\/\/doi.org\/10.1210\/endo.139.4.5931","journal-title":"Endocrinology"},{"issue":"12","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1210\/en.2004-0061","volume":"145","author":"GM Leong","year":"2004","unstructured":"Leong GM, Moverare S, Brce J, Doyle N, Sjogren K, Dahlman-Wright K et al (2004) Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology 145(12):5525\u20135531. https:\/\/doi.org\/10.1210\/en.2004-0061","journal-title":"Endocrinology"},{"issue":"2","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1172\/JCI105982","volume":"48","author":"E Schwartz","year":"1969","unstructured":"Schwartz E, Echemendia E, Schiffer M, Panariello VA (1969) Mechanism of estrogenic action in acromegaly. J Clin Investig 48(2):260\u2013270. https:\/\/doi.org\/10.1172\/JCI105982","journal-title":"J Clin Investig"},{"issue":"11","key":"1204_CR26","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/jcem.84.11.6113","volume":"84","author":"DM Cook","year":"1999","unstructured":"Cook DM, Ludlam WH, Cook MB (1999) Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 84(11):3956\u20133960. https:\/\/doi.org\/10.1210\/jcem.84.11.6113","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1204_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF03345183","volume":"26","author":"R Cozzi","year":"2003","unstructured":"Cozzi R, Barausse M, Lodrini S, Lasio G, Attanasio R (2003) Estroprogestinic pill normalizes IGF-I levels in acromegalic women. J Endocrinol Invest 26(4):347\u2013352. https:\/\/doi.org\/10.1007\/BF03345183","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1204_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11102-010-0236-5","volume":"13","author":"S Vallette","year":"2010","unstructured":"Vallette S, Serri O (2010) Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly? Pituitary 13(4):311\u2013314. https:\/\/doi.org\/10.1007\/s11102-010-0236-5","journal-title":"Pituitary"},{"issue":"2","key":"1204_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1172\/JCI14264","volume":"109","author":"AP Heaney","year":"2002","unstructured":"Heaney AP, Fernando M, Melmed S (2002) Functional role of estrogen in pituitary tumor pathogenesis. J Clin Investig 109(2):277\u2013283. https:\/\/doi.org\/10.1172\/JCI14264","journal-title":"J Clin Investig"},{"issue":"3","key":"1204_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11102-013-0504-2","volume":"17","author":"JC Stone","year":"2014","unstructured":"Stone JC, Clark J, Cuneo R, Russell AW, Doi SA (2014) Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies. Pituitary 17(3):284\u2013295. https:\/\/doi.org\/10.1007\/s11102-013-0504-2","journal-title":"Pituitary"},{"issue":"5","key":"1204_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0010-7824(00)00176-1","volume":"62","author":"A Balogh","year":"2000","unstructured":"Balogh A, Kauf E, Vollanth R, Graser G, Klinger G, Oettel M (2000) Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH). Contraception 62(5):259\u2013269. https:\/\/doi.org\/10.1016\/s0010-7824(00)00176-1","journal-title":"Contraception"},{"issue":"4","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11102-012-0426-4","volume":"15","author":"I Shimon","year":"2012","unstructured":"Shimon I, Barkan A (2012) Estrogen treatment for acromegaly. Pituitary 15(4):601\u2013607. https:\/\/doi.org\/10.1007\/s11102-012-0426-4","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-021-01204-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T21:08:08Z","timestamp":1654549688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-021-01204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s11102-021-01204-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"16 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Instituto Estadual do C\u00e9rebro Paulo Niemeyer (Approval number: CAAE: 72415017.2.0000.8110).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}